Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) have been given a consensus rating of “Moderate Buy” by the fifteen research firms that are covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average […]

Related Keywords

California , United States , Sanfordc Bernstein , Davidw Meline , Pacific Biosciences , Piper Sandler , Nasdaq , Moody Aldrich Partners , Victory Capital Management Inc , Morgan Stanley , Barclays , Scotiabank , Qube Research Technologies Ltd , California Inc , Investment Management , Get Free Report , Director David , Capital Management , Aldrich Partners , Qube Research , Technologies Ltd , California Price , Get Free , California Daily ,